Aarhus University Seal / Aarhus Universitets segl

Esben Skipper Sørensen

An albumin-oligonucleotide assembly for potential combinatorial drug delivery and half-life extension applications

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Standard

An albumin-oligonucleotide assembly for potential combinatorial drug delivery and half-life extension applications. / Kuhlmann, Matthias; Hamming, Jonas Bohn Refslund; Voldum, Anders ; Tsakiridou, Georgia; Larsen, Maja Thim; Schmøkel, Julie; Sohn, Emil ; Bienk, Konrad; Schaffert, David Henning; Sørensen, Esben Skipper; Wengel, Jesper; Dupont, Daniel Miotto; Howard, Ken.

In: Molecular Therapy - Nucleic Acids, Vol. 9, 15.12.2017, p. 284-293.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Harvard

Kuhlmann, M, Hamming, JBR, Voldum, A, Tsakiridou, G, Larsen, MT, Schmøkel, J, Sohn, E, Bienk, K, Schaffert, DH, Sørensen, ES, Wengel, J, Dupont, DM & Howard, K 2017, 'An albumin-oligonucleotide assembly for potential combinatorial drug delivery and half-life extension applications', Molecular Therapy - Nucleic Acids, vol. 9, pp. 284-293. https://doi.org/10.1016/j.omtn.2017.10.004

APA

Kuhlmann, M., Hamming, J. B. R., Voldum, A., Tsakiridou, G., Larsen, M. T., Schmøkel, J., ... Howard, K. (2017). An albumin-oligonucleotide assembly for potential combinatorial drug delivery and half-life extension applications. Molecular Therapy - Nucleic Acids, 9, 284-293. https://doi.org/10.1016/j.omtn.2017.10.004

CBE

Kuhlmann M, Hamming JBR, Voldum A, Tsakiridou G, Larsen MT, Schmøkel J, Sohn E, Bienk K, Schaffert DH, Sørensen ES, Wengel J, Dupont DM, Howard K. 2017. An albumin-oligonucleotide assembly for potential combinatorial drug delivery and half-life extension applications. Molecular Therapy - Nucleic Acids. 9:284-293. https://doi.org/10.1016/j.omtn.2017.10.004

MLA

Vancouver

Kuhlmann M, Hamming JBR, Voldum A, Tsakiridou G, Larsen MT, Schmøkel J et al. An albumin-oligonucleotide assembly for potential combinatorial drug delivery and half-life extension applications. Molecular Therapy - Nucleic Acids. 2017 Dec 15;9:284-293. https://doi.org/10.1016/j.omtn.2017.10.004

Author

Kuhlmann, Matthias ; Hamming, Jonas Bohn Refslund ; Voldum, Anders ; Tsakiridou, Georgia ; Larsen, Maja Thim ; Schmøkel, Julie ; Sohn, Emil ; Bienk, Konrad ; Schaffert, David Henning ; Sørensen, Esben Skipper ; Wengel, Jesper ; Dupont, Daniel Miotto ; Howard, Ken. / An albumin-oligonucleotide assembly for potential combinatorial drug delivery and half-life extension applications. In: Molecular Therapy - Nucleic Acids. 2017 ; Vol. 9. pp. 284-293.

Bibtex

@article{ad39439cda2945b8b593957e5522131b,
title = "An albumin-oligonucleotide assembly for potential combinatorial drug delivery and half-life extension applications",
author = "Matthias Kuhlmann and Hamming, {Jonas Bohn Refslund} and Anders Voldum and Georgia Tsakiridou and Larsen, {Maja Thim} and Julie Schm{\o}kel and Emil Sohn and Konrad Bienk and Schaffert, {David Henning} and S{\o}rensen, {Esben Skipper} and Jesper Wengel and Dupont, {Daniel Miotto} and Ken Howard",
year = "2017",
month = "12",
day = "15",
doi = "10.1016/j.omtn.2017.10.004",
language = "English",
volume = "9",
pages = "284--293",
journal = "Molecular Therapy - Nucleic Acids",
issn = "2162-2531",
publisher = "Nature Publishing Group",

}

RIS

TY - JOUR

T1 - An albumin-oligonucleotide assembly for potential combinatorial drug delivery and half-life extension applications

AU - Kuhlmann, Matthias

AU - Hamming, Jonas Bohn Refslund

AU - Voldum, Anders

AU - Tsakiridou, Georgia

AU - Larsen, Maja Thim

AU - Schmøkel, Julie

AU - Sohn, Emil

AU - Bienk, Konrad

AU - Schaffert, David Henning

AU - Sørensen, Esben Skipper

AU - Wengel, Jesper

AU - Dupont, Daniel Miotto

AU - Howard, Ken

PY - 2017/12/15

Y1 - 2017/12/15

U2 - 10.1016/j.omtn.2017.10.004

DO - 10.1016/j.omtn.2017.10.004

M3 - Journal article

VL - 9

SP - 284

EP - 293

JO - Molecular Therapy - Nucleic Acids

JF - Molecular Therapy - Nucleic Acids

SN - 2162-2531

ER -